Boston U. researchers examine new treatments for alcoholismEmily Latham
New pharmacotherapies for alcohol dependence. MJA - Graham, AD, et al. () Citation Context ... treatments to prevent craving and relapse to alcohol abuse after detoxification and periods of abstinence. Treatment options currently include the drugs naltrexone (Revia) and acamprosate (Campral) (=...
No specific treatments are available for those patients who are steroid ineligible, intolerant or unresponsive. Liver transplant has shown good short-term outcome; however, feasibility, ethical and economic concerns remain. Modification of gut microbiota composition and their products, such as ...
PL2ETHANOL'S INTERACTION WITH BRAIN DOPAMINE SYSTEMS PROVIDES CLUES FOR NEW TREATMENTS OF ALCOHOLISM doi:10.1093/alcalc/agx073.02GREECEBRAIN physiologyALCOHOLISMCONFERENCES & conventionsDOPAMINEDRUG interactionsETHANOLAlcohol & Alcoholism. SupplementSderpalm, B...
Novel anticonvulsants in the treatment of alcoholism There have been many recent developments in the pharmacological management of alcohol withdrawal and alcohol dependence. Although previous treatments had i... SW Book,H Myrick - 《Expert Opin Investig Drugs》 被引量: 125发表: 2005年 Topiramate in...
Recognizing the influence of gender, treatments are often tailored, as men and women may experience and respond to addiction differently. For some, partial hospitalization programs provide a structured yet flexible approach, offering intensive care during the day while allowing patients to spend nights ...
For the treatment of alcoholism, disulfiram has been joined by naltrexone. and soon acamprosate will be added to the list of available pharmacotherapies. Individuals with opiate dependence who, for 25 years. were limited to a single medication (methadone) now have LAAM as an available treatment...
Currently, there are only a handful of treatments for alcoholism approved by the Food and Drug Administration. By testing the effect of the substance in reducing ethanol consumption in mice—in addition to its previously reported link in reducing depression-like symptoms—the findings may point the...
offers comprehensive outpatient medication-assisted treatment (MAT) programs in Bridgeport and New Haven, Connecticut. These programs include Methadone, Suboxone, and Vivitrol treatments, providing essential support for individuals seeking recovery from Opioid Use ...
CERC-501, a potent, selective, short-acting kappa antagonist, is currently (late 2016) undergoing trials as an antidepressant and potential treatment for alcoholism and nicotine dependence. In the meantime, Buprenorphine (Buprenex, Temgesic, Subutex), for instance, is certainly no panacea; but ...